Webinar Details
Recorded on November 16, 2023
Speaker: Josh Apgar, PhD, Co-founder and CSO at Applied BioMath
Abstract: This is an introductory case study showing how Applied BioMath Assess™ can be used early in drug R&D to gain insight into project feasibility. Specifically in this case study, we'll discuss how to account for more complex design considerations and make a best-in-class bispecific drug. You'll learn how to:
- Set up a model using data on PD1 and CTLA4
- Benchmark the model using PK/PD data for Lorigerlimab
- Identify best in class parameters for a PD1/CTLA4